Tags: Cancer | Keytruda | FDA | blood | cancer | Hodgkin | lymphoma

Keytruda Wins FDA Nod for Treating Blood Cancer

Image: Keytruda Wins FDA Nod for Treating Blood Cancer
(Copyright Stock Photo Secrets)

Wednesday, 15 Mar 2017 04:55 PM

Merck & Co Inc said on Tuesday it had got a nod from the U.S. Food and Drug Administration for its already-approved immunotherapy drug Keytruda as a treatment for a type of blood cancer.

The nod from the FDA marks the first approval of the treatment for blood cancer. Keytruda is already approved for treating lung, head and neck cancers, among others.

The drug, administered intravenously, has been approved for use in adults at a fixed dose of 200 mg and in children at a dose of 2 mg/kg for refractory classical Hodgkin lymphoma, a type of cancer that starts in white blood cells.

The drug was approved under the FDA's accelerated approval program which allows for quicker approval of drugs that fill an unmet medical need.

When a drugmaker wins accelerated approval, the company must provide further evidence of the drug's benefit to satisfy the regulator, failing which the approval can be revoked.

© 2017 Thomson/Reuters. All rights reserved.

   
1Like our page
2Share
Health-News
Merck & Co Inc said on Tuesday it had got a nod from the U.S. Food and Drug Administration for its already-approved immunotherapy drug Keytruda as a treatment for a type of blood cancer.The nod from the FDA marks the first approval of the treatment for blood cancer....
Keytruda, FDA, blood, cancer, Hodgkin, lymphoma
154
2017-55-15
Wednesday, 15 Mar 2017 04:55 PM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved